Low Back Pain
Conditions
Brief summary
The investigators propose to carry out a study evaluating the effectiveness of the MDT method (mechanical diagnosis and therapy) in the subacute phase of common low back pain. Few studies have specifically evaluated the effectiveness of the MDT method in the subacute phase, a phase that appears to be crucial before the chronicization of low back pain. The main objective of this study will be to evaluate the pain of patients managed by the MDT method. The analysis of the main criterion (Visual Analog Scale) will be done using a type individual clinical trial specific: the Single Case Experimental Design or SCED in lines of multiple bases. This type of study makes it possible to carry out a comparative test on a single subject acting as its own witness in order to obtain an acceptable level of evidence response for that particular patient.
Interventions
OTHERMDT (mechanical diagnosis and therapy) method
The intervention consists of a first session to carry out an assessment, followed by 4 reassessment sessions
Sponsors
Nantes University Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Consultant patients at the Picasso physiotherapy practice (5 rue Nina Simone - 44 000 NANTES) * Aged 18 to 55 years old * Suffering from common-looking low back pain. Low back pain is defined as pain or localized discomfort under the 12th dorsal vertebrae and above the inner fold buttock, with possible irradiation to the lower limb but not exceeding the knee. * Evolving for 4 to 12 weeks (subacute period). * Period preceded by a period of 30 days without low back pain (in order to avoid recurrent low back pain, rather similar to the chronic phase).
Exclusion criteria
* Signs of specific low back pain (confirmed or highly suspected diagnosis): fracture, infection, osteoporosis, inflammatory disease, tumor * Irradiation below the knee * Patient knowing she is pregnant * Protected adults * Patient with proven cognitive impairment * Patient with a decompensated psychiatric pathology * Incapacity to consent * Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evolution over time of patients' pain | 3 months | The main outcome will be the evolution over time of patients' pain as assessed by a visual analogue scale completed daily by the patient himself. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Evolution of the pain localization will be done on a body chart filled daily by the patient | 3 months | Evolution of the pain localization will be done on a body chart filled daily by the patient |
| Evolution of drug consumption through a completed questionnaire daily by the patient | 3 months | Evolution of drug consumption through a completed questionnaire daily by the patient |
| Evolution of functional disability through the EIFEL questionnaire | 3 months | Evolution of functional disability through the EIFEL questionnaire |
| Evolution of beliefs and fears through the FABQ (Fear Avoidance Belief) questionnaire | 3 months | Evolution of beliefs and fears through the FABQ (Fear Avoidance Belief) questionnaire |
| Evolution of psychosocial factors by STarT Back | 3 months | Evolution of psychosocial factors by STarT Back |
Countries
France
Contacts
Primary ContactCeline BOUTON, Professor
Outcome results
None listed